TTK and ovarian serous carcinoma: China recently did a lot of work in the discovery of multiple drug resistance mechanisms, including overexpression of the USP11-BIP axis leading to drug resistance (21), significantly upregulated TTK expression in high-grade serous ovarian carcinoma (HGSOC), and cisplatin-resistant ovarian cancer cells (22).